EASD_Virtual Tour_SU_RFP-Reception Entrance - no brand.jpg

Eli Lilly and Company

Enhancing Lilly’s virtual attendance at EASD.

To support Lilly’s virtual attendance at EASD, we designed multiple virtual rooms, all distinctly different to support their developments in insulin, glucagon, and pens.

Attendees had a full immersive experience with water feature sounds, simulations, 3D interactive models of the clients’ medical devices, linked to “how-to-use” videos, and an animated “host” character who provided an overview of each area on arrival - complemented with live updates (data releases and on-demand videos from live presentations sponsored by the client during  EASD).

The tour could be navigated using the interface or by using a side menu.

 

Specifications

Event EASD Virtual Exhibit & Symposium

Country 10x different countries represented

Industry Pharmaceuticals

Participants Healthcare Providers

 
Floorplan - Lilly EASD Virtual Tour MOCKUP - web.png
TRULICITY Entrance - Lilly EASD Virtual Tour MOCKUP - web.png
 

 

50%

Viewed new-to-market product video.

7,178

Unique clicks on branded & medical content

21:21

Average time in tour, mins/secs.

4.56%

Bounce rate.

 

 
QS Entrance (no brand) - Lilly EASD Virtual Tour MOCKUP - web.png
Lilly created an eye catching, informational, and compelling experience with its exhibit. Overall, it seems incredibly smart of Lilly to clearly invest in virtual exhibition - it has, at EASD, gone above and beyond in its delivery of information. Lilly’s exhibit was a clear go-to for anyone curious about the newest developments in insulin, glucagon, and pens.
— Third Party review: closeconcerns.com
TRULICITY Centre - Lilly EASD Virtual Tour MOCKUP - Web.png
TRULICITY Entrance - Lilly EASD Virtual Tour MOCKUP - web.png
 
 
I wanted to send you a big thank you for the work you and your team has done around this year’s booth; we’re receiving lots of congratulatory emails, and that’s thanks to you and your team. Our attendees loved the experience! Again, thank you!
— Client, Eli Lilly and Company